drugset / Trial / NCT03806790

Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

NCT03806790

Phase 3 Completed 182 enrolled LEO Pharma
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of the efficacy of LEO 90100 foam with Dovobet® ointment in the treatment of psoriasis in Japanese subjects.

Timeline

Start
2019-01-24
Primary completion
2019-06-10
Completion
2019-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical
Comparator betamethasone dipropionate Small molecule Topical

Indications